Alterations in CD8+CD45RA+CCR7− T cells as a potential biomarker for primary Sjögren's syndrome

In this study, we found that the CD8+CD45RA+CCR7− T cell subpopulation was increased in the peripheral blood of patients with primary Sjögren's syndrome (pSS) compared with healthy donors. Moreover, both CD8+TIM-3+ T cells and CD8+CD45RA+CCR7− T cells were positively correlated with serum anti-...

Full description

Bibliographic Details
Published in:	Immunobiology
Main Authors:	Jie Pan, Rongqiang Wu, Liuyang He, Yu Bai, Jun Ding, Yan Wang, Shu Fan, Zhengyu Zhang, Ping Zhang, Chunjian Qi
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Subjects:	Sjögren's syndrome T Cell Subset Β-Glucan Hydroxychloroquine sulfate
Online Access:	http://www.sciencedirect.com/science/article/pii/S0171298525000488

Similar Items

Circulating CD8+ T Cell Subsets in Primary Sjögren’s Syndrome
by: Igor Kudryavtsev, et al.
Published: (2023-10-01)

Forgotten Effect of Hydroxychloroquine in the Sjogren’s Syndrome: Ototoxicity
by: Yüce İslamoğlu, et al.
Published: (2021-04-01)

Azathioprine and hydroxychloroquine overdose in Sjögren’s syndrome patient with hypocalcemia: a case report
by: Alireza Kooshki, et al.
Published: (2024-02-01)

A Case of Treatment with Steroid and Hydrochloroquine of Thrombocytopenia in Primary Sjögren's Syndrome
by: Yeong Seop Yun, et al.
Published: (2017-06-01)

Increased risk of dementia in patients with primary Sjogren’s syndrome: a nationwide population-based cohort study
by: Kyung-Ann Lee, et al.
Published: (2025-03-01)

Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review
by: Aiping Zhang, et al.
Published: (2023-10-01)

A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren’s syndrome patients
by: Wei Bai, et al.
Published: (2023-02-01)

Proteins linked to type II interferon response in Sjögren’s disease: novel indicators for disease monitoring and predicting treatment response to leflunomide and hydroxychloroquine combination therapy
by: Wing-Yi Wong, et al.
Published: (2025-10-01)

Comparison of the effect of iguratimod and hydroxychloroquine on regulatory B cells in the treatment of primary Sjögren’s syndrome
by: Jin-Mei Zou, et al.
Published: (2025-07-01)

T Cells Subsets in the Immunopathology and Treatment of Sjogren’s Syndrome
by: William de Jesús Ríos-Ríos, et al.
Published: (2020-11-01)

Improved Fatigue Management in Primary Sjögren’s Syndrome: A Retrospective Analysis of the Efficacy of Methotrexate in Chinese Patients
by: Zhou M, et al.
Published: (2024-10-01)

Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren’s syndrome
by: Ketty Lysie Libardi Lira Machado, et al.
Published: (2024-12-01)

CD8+ T Lymphocytes: Crucial Players in Sjögren’s Syndrome
by: Huimin Zhou, et al.
Published: (2021-01-01)

Features of B cell subsets in primary Sjogren’s syndrome and systemic lupus erythematosus
by: S. S. Benevolenskaya, et al.
Published: (2024-11-01)

Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells
by: Magdalena J. Polanczyk, et al.
Published: (2019-07-01)

Comparative outcomes of COVID-19 in patients with primary Sjögren’s syndrome treated with hydroxychloroquine versus methotrexate: a retrospective cohort study
by: Jih-Jin Tsai, et al.
Published: (2025-12-01)

Lymphoma Associated with Sjögren's Syndrome
by: Tuğba Aktan Köşker, et al.
Published: (2013-12-01)

The evolution of international classification criteria for Sjogren’s syndrome
by: J. I. Khvan, et al.
Published: (2024-01-01)

The proportion of CD161 on CD56+ NK cells in peripheral circulation associates with clinical features and disease activity of primary Sjögren's syndrome
by: Ping Zhao, et al.
Published: (2024-04-01)

ARTICULAR DAMAGE IN SJOGREN’S DISEASE
by: N S Shornikova, et al.
Published: (2002-02-01)

Pulmonary Involvement Caused by Primary Sjogren’s Syndrome: The Pilot phase of Iran Primary Sjogren’s Syndrome Registry
by: Asghar Hajiabbasi, et al.
Published: (2025-07-01)

The role of hydroxychloroquine sulfate in the geriatric patient with coronavirus disease 2019 (COVID-19). What is useful to know for the geriatrician?
by: Ciro Manzo
Published: (2020-04-01)

β-Glucan induced plasma B cells differentiation to enhance antitumor immune responses by Dectin-1
by: Yu Bai, et al.
Published: (2025-01-01)

Sjogren's Syndrome
by: Pyar Ali Fazel, et al.
Published: (2007-04-01)

Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome
by: Mana Iizuka-Koga, et al.
Published: (2017-05-01)

IL-27 Regulated CD4+IL-10+ T Cells in Experimental Sjögren Syndrome
by: Jingjing Qi, et al.
Published: (2020-08-01)

CD4+, CD8+ and CD4+CD25+ T lymphocytes in peripheral blood and peritoneal fluid of women with endometriosis - preliminary report
by: Jarosław Górski, et al.
Published: (2007-03-01)

Correlation between circulating CD4+CD45RA+CD62L+ T cells and prognosis of metastatic non-small cell lung cancer treated with EGFR-TKI
by: CAO Chenxin, TANG Hui, GENG Ruixuan, GUO Fuping, BAI Chunmei, WANG Yingyi, LI Taisheng
Published: (2024-05-01)

QUADRIPARESIS IN SJOGREN SYNDROME
by: Nikhil Srivastva, et al.
Published: (2015-06-01)

Pain in Sjögren’s syndrome
by: C. Giacomelli, et al.
Published: (2014-06-01)

Investigating the common genes involved in development of Sjogren's syndrome and Cardiomyopathy
by: Anwer Aldhaheri, et al.
Published: (2025-06-01)

Altered subgroups of regulatory T cells in patients with primary Sjögren's syndrome
by: Jing-Chi Lin, et al.
Published: (2023-05-01)

CD226+ B cells in primary Sjögren’s syndrome: a key player in clinical manifestations and disease pathogenesis
by: Ping Zhao, et al.
Published: (2025-07-01)

Tear film microbiome in Sjogren's and non-Sjogren's aqueous deficiency dry eye
by: Spandita Pal, et al.
Published: (2023-01-01)

A focus on Sjogren’s Dry Eye Disease - pathogenesis, patient management, and new advancements in therapy
by: Ewa Uram, et al.
Published: (2023-08-01)

Demographic, Clinical and Serological Characteristics of the Patients with Sjögren’s Syndrome: A Tertiary Clinic Experience
by: Nurdan Yılmaz, et al.
Published: (2020-08-01)

Decreased IgD- CD27- double negative B cells in Sjögren’s disease correlated with disease activity index
by: Lin Zhao, et al.
Published: (2025-10-01)

Meibomian gland dysfunction in Sjögren's disease
by: Esther N. Anuwa-Amarh, et al.
Published: (2025-08-01)

Thymoma combined with Sjogren's syndrome: A case report
by: Yuan-Chao Cao, et al.
Published: (2025-04-01)

Immune Monitoring upon Treatment with Biologics in Sjögren’s Syndrome: The What, Where, When, and How
by: Joyce J.B.C. van Beers, et al.
Published: (2021-01-01)